Sort   by:  
 Page size 
UnknownNovel inhibitors that target bacterial virulence identified via HTS against intra-macrophage survival of Shigella flexneri.
Not available
S-EPMC10597453 | biostudies-literature
UnknownSubcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial.
Not available
S-EPMC10005687 | biostudies-literature
UnknownA Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
Not available
S-EPMC8258773 | biostudies-literature
UnknownNLRC4-mediated activation of CD1c+ DC contributes to perpetuation of synovitis in rheumatoid arthritis.
Not available
S-EPMC9746818 | biostudies-literature
UnknownBroad band high resolution rotational spectroscopy for Laboratory Astrophysics.
Not available
S-EPMC6557716 | biostudies-literature
UnknownAlpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
Not available
S-EPMC8380059 | biostudies-literature
UnknownRapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.
Not available
S-EPMC6704069 | biostudies-literature
UnknownMICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity.
Not available
S-EPMC10690448 | biostudies-literature
UnknownPatients awaiting surgery for neurosurgical diseases during the first wave of the COVID-19 pandemic in Spain: a multicentre cohort study.
Not available
S-EPMC9388715 | biostudies-literature
UnknownRisk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
Not available
S-EPMC9896606 | biostudies-literature
Sort   by:  
 Page size